tirzepatide aka Lilly Shows Superiority in SURMOUNT-3 and 4 GLP-2 Tirzepatide – Tirzepatide Research Peptide 10mg, 20

Mo1908: Glucagon-like peptide-1 receptor agonist use in patients with perianal fistulizing Crohn's disease is well tolerated and leads to weight loss and clinical improvement in fistula activity

Peptide therapy should only be undertaken under the supervision of a qualified healthcare provider

For more on why appetite support matters post-GLP-1, our guide covers the transition in detail

The global nature of the drug supply chain also adds a layer of regulatory complexity

So, fix your lifestyle too

The decision to use GLP-1 receptor agonists should be made on an individual basis, weighing the potential benefits against the risks for each patient